Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
R1 RCM ( (RCM) ) has issued an update.
TowerBrook Capital Partners and Clayton, Dubilier & Rice have completed their acquisition of R1 RCM, a leader in healthcare revenue management, making it a privately held company. With this acquisition, valued at approximately $8.9 billion, R1’s common stock will no longer trade on Nasdaq. Joe Flanagan has been reappointed as CEO of R1, aiming to drive innovation and enhance customer value through advanced automation. The deal, supported by major financial institutions, underscores R1’s commitment to transforming healthcare financial performance.
Learn more about RCM stock on TipRanks’ Stock Analysis page.
